Evaluation of the Cosmetic Efficacy of Salmon Tissue-Derived Exosomes and Plasmatherapy in Patients with Androgenetic Alopecia: A Randomized Controlled Clinical Trial

    Olga Olisova, Vera Smolyannikova, Karim Karray, Anfisa Lepekhova
    Image of study
    TLDR Salmon tissue-derived exosomes improve hair growth better than platelet-rich plasma for treating hair loss.
    This randomized controlled clinical trial assessed the efficacy of salmon tissue-derived exosomes and plasmatherapy (PRP) in treating androgenetic alopecia in 40 patients. Participants were divided into two groups, with one receiving exosome treatment and the other PRP. The study found that both treatments significantly improved hair density, but the exosome group showed superior results, with hair density increasing from 102.6 to 147.0 hairs/cm² compared to 101.8 to 128.1 hairs/cm² in the PRP group. Additionally, the exosome group experienced greater improvements in anagen hair percentage, hair diameter, and a reduction in vellus hair percentage. These results suggest that salmon tissue-derived exosomes may be a more effective treatment option for enhancing hair growth in patients with androgenetic alopecia.
    Discuss this study in the Community →

    Research cited in this study

    17 / 17 results